{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:23:11Z","timestamp":1791894191363,"version":"4.3.4"},"reference-count":66,"publisher":"The Ewha Medical Journal, Ewha Womans University College of Medicine","issue":"s1","license":[{"start":{"date-parts":[[2023,12,31]],"date-time":"2023-12-31T00:00:00Z","timestamp":1703980800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["www.e-emj.org"],"crossmark-restriction":true},"short-container-title":["Ewha Med J"],"DOI":"10.12771\/emj.2023.e33","type":"journal-article","created":{"date-parts":[[2024,1,15]],"date-time":"2024-01-15T05:47:44Z","timestamp":1705297664000},"update-policy":"https:\/\/doi.org\/10.12771\/crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Updates on Obesity in Prader-Willi Syndrome: From Genetics to Management"],"prefix":"10.12771","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4664-1941","authenticated-orcid":false,"given":"Young Bae","family":"Sohn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8818-4419","authenticated-orcid":false,"given":"Ji Eun","family":"Moon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-6560-1888","authenticated-orcid":false,"given":"Yeo Jin","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-2197-5224","authenticated-orcid":false,"given":"Young Ae","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4998","published-online":{"date-parts":[[2023,12,31]]},"reference":[{"issue":"4","key":"key2.024011506525e+13_B1","doi-asserted-by":"crossref","first-page":"207","DOI":"10.2174\/1573396315666190716120925","article-title":"Prader-Willi syndrome: clinical genetics, diagnosis and treatment approaches: an update","volume":"15","author":"Butler","year":"2019","journal-title":"Curr Pediatr Rev"},{"issue":"5","key":"key2.024011506525e+13_B2","doi-asserted-by":"crossref","first-page":"R149","DOI":"10.1530\/EJE-20-0363","article-title":"MECHANISMS IN ENDOCRINOLOGY: update on treatments for patients with genetic obesity","volume":"183","author":"Poitou","year":"2020","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"key2.024011506525e+13_B3","doi-asserted-by":"crossref","first-page":"4271","DOI":"10.3390\/ijms24054271","article-title":"Prader\u2013Willi syndrome and chromosome 15q11.2 BP1-BP2 region: a review","volume":"24","author":"Butler","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"3","key":"key2.024011506525e+13_B4","doi-asserted-by":"crossref","first-page":"169","DOI":"10.6065\/apem.2244188.094","article-title":"Genetic obesity: an update with emerging therapeutic approaches","volume":"27","author":"Sohn","year":"2022","journal-title":"Ann Pediatr Endocrinol Metab"},{"issue":"12","key":"key2.024011506525e+13_B5","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1007\/s40618-015-0312-9","article-title":"Prader-Willi syndrome: a review of clinical, genetic, and endocrine findings","volume":"38","author":"Angulo","year":"2015","journal-title":"J Endocrinol Invest"},{"issue":"1","key":"key2.024011506525e+13_B6","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/gim.0b013e31822bead0","article-title":"Prader-Willi syndrome","volume":"14","author":"Cassidy","year":"2012","journal-title":"Genet Med"},{"key":"key2.024011506525e+13_B7","doi-asserted-by":"crossref","first-page":"579","DOI":"10.2147\/DMSO.S141352","article-title":"Obesity management in Prader\u2013Willi syndrome: current perspectives","volume":"11","author":"Crin\u00f2","year":"2018","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"4","key":"key2.024011506525e+13_B8","doi-asserted-by":"crossref","first-page":"227","DOI":"10.6065\/apem.2142164.082","article-title":"Prader-Willi syndrome: an update on obesity and endocrine problems","volume":"26","author":"Kim","year":"2021","journal-title":"Ann Pediatr Endocrinol Metab"},{"issue":"1","key":"key2.024011506525e+13_B9","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/gim.2017.92","article-title":"Survival trends from the Prader\u2013Willi syndrome association (USA) 40-year mortality survey","volume":"20","author":"Manzardo","year":"2018","journal-title":"Genet Med"},{"issue":"10","key":"key2.024011506525e+13_B10","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1038\/ijo.2017.139","article-title":"Long-term health outcomes in patients with Prader\u2013Willi syndrome: a nationwide cohort study in Denmark","volume":"41","author":"Hedgeman","year":"2017","journal-title":"Int J Obes"},{"issue":"2","key":"key2.024011506525e+13_B11","doi-asserted-by":"crossref","first-page":"148","DOI":"10.6065\/apem.2142022.011","article-title":"Tailored management of life-threatening complications related to severe obesity in a young adult with Prader-Willi syndrome","volume":"27","author":"Kim","year":"2022","journal-title":"Ann Pediatr Endocrinol Metab"},{"issue":"4","key":"key2.024011506525e+13_B12","doi-asserted-by":"crossref","first-page":"289","DOI":"10.6065\/apem.2142230.115","article-title":"Cardiometabolic risk factors and metabolic syndrome based on severity of obesity in Korean children and adolescents: data from the Korea National Health and Nutrition Examination Survey 2007\u20132018","volume":"27","author":"Kim","year":"2022","journal-title":"Ann Pediatr Endocrinol Metab"},{"issue":"3","key":"key2.024011506525e+13_B13","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1067\/S0022-3476(03)00386-X","article-title":"Decreased energy expenditure is caused by abnormal body composition in infants with Prader-Willi syndrome","volume":"143","author":"Bekx","year":"2003","journal-title":"J Pediatr"},{"issue":"9","key":"key2.024011506525e+13_B14","doi-asserted-by":"crossref","first-page":"4330","DOI":"10.1210\/jcem.86.9.7814","article-title":"Visceral adipose tissue and metabolic complications of obesity are reduced in Prader-Willi syndrome female adults: evidence for novel influences on body fat distribution","volume":"86","author":"Goldstone","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"key2.024011506525e+13_B15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.pmbts.2015.12.003","article-title":"Single gene and syndromic causes of obesity: illustrative examples","volume":"140","author":"Butler","year":"2016","journal-title":"Prog Mol Biol Transl Sci"},{"key":"key2.024011506525e+13_B16","doi-asserted-by":"crossref","first-page":"154","DOI":"10.3389\/fped.2020.00154","article-title":"Chromosome 15 imprinting disorders: genetic laboratory methodology and approaches","volume":"8","author":"Butler","year":"2020","journal-title":"Front Pediatr"},{"issue":"3","key":"key2.024011506525e+13_B17","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1136\/jmedgenet-2018-105301","article-title":"Molecular genetic classification in Prader-Willi syndrome: a multisite cohort study","volume":"56","author":"Butler","year":"2019","journal-title":"J Med Genet"},{"key":"key2.024011506525e+13_B18","doi-asserted-by":"crossref","first-page":"608889","DOI":"10.3389\/fgene.2021.608889","article-title":"A streamlined approach to Prader-Willi and Angelman syndrome molecular diagnostics","volume":"12","author":"Strom","year":"2021","journal-title":"Front Genet"},{"issue":"1","key":"key2.024011506525e+13_B19","doi-asserted-by":"crossref","first-page":"5","DOI":"10.5582\/irdr.2022.01127","article-title":"Hyperphagia in Prader-Willi syndrome with obesity: from development to pharmacological treatment","volume":"12","author":"Rahman","year":"2023","journal-title":"Intractable Rare Dis Res"},{"issue":"3","key":"key2.024011506525e+13_B20","doi-asserted-by":"crossref","first-page":"126","DOI":"10.6065\/apem.2016.21.3.126","article-title":"Genetics of Prader-Willi syndrome and Prader-Will-like syndrome","volume":"21","author":"Cheon","year":"2016","journal-title":"Ann Pediatr Endocrinol Metab"},{"issue":"12","key":"key2.024011506525e+13_B21","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.137495","article-title":"Loss of Snord116 impacts lateral hypothalamus, sleep, and food-related behaviors","volume":"5","author":"Pace","year":"2020","journal-title":"JCI Insight"},{"issue":"3","key":"key2.024011506525e+13_B22","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/ajmg.c.30273","article-title":"Prader\u2013Willi syndrome and Angelman syndrome","volume":"154C","author":"Buiting","year":"2010","journal-title":"Am J Med Genet C Semin Med Genet"},{"issue":"S423","key":"key2.024011506525e+13_B23","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1651-2227.1997.tb18369.x","article-title":"Prader\u2014Willi syndrome and the hypothalamus","volume":"86","author":"Swaab","year":"1997","journal-title":"Acta Paediatr"},{"issue":"8","key":"key2.024011506525e+13_B24","doi-asserted-by":"crossref","first-page":"4228","DOI":"10.1002\/hbm.23660","article-title":"Brain structural alterations in obese children with and without Prader-Willi syndrome","volume":"38","author":"Xu","year":"2017","journal-title":"Hum Brain Mapp"},{"issue":"3","key":"key2.024011506525e+13_B25","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1172\/JCI97007","article-title":"Hypothalamic loss of Snord116 recapitulates the hyperphagia of Prader-Willi syndrome","volume":"128","author":"Polex-Wolf","year":"2018","journal-title":"J Clin Invest"},{"issue":"9","key":"key2.024011506525e+13_B26","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1007\/s10803-008-0546-x","article-title":"Food-related neural circuitry in Prader-Willi syndrome: response to high-versus low-calorie foods","volume":"38","author":"Dimitropoulos","year":"2008","journal-title":"J Autism Dev Disord"},{"key":"key2.024011506525e+13_B27","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.brainres.2015.05.008","article-title":"The neurobiological drive for overeating implicated in Prader\u2013Willi syndrome","volume":"1620","author":"Zhang","year":"2015","journal-title":"Brain Res"},{"issue":"12","key":"key2.024011506525e+13_B28","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1038\/ijo.2011.274","article-title":"Appetite hormones and the transition to hyperphagia in children with Prader-Willi syndrome","volume":"36","author":"Goldstone","year":"2012","journal-title":"Int J Obes"},{"issue":"8","key":"key2.024011506525e+13_B29","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.metabol.2007.03.016","article-title":"Free and total leptin serum levels and soluble leptin receptors levels in two models of genetic obesity: the Prader-Willi and the Down syndromes","volume":"56","author":"Proto","year":"2007","journal-title":"Metabolism"},{"issue":"9","key":"key2.024011506525e+13_B30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0163468","article-title":"Lack of postprandial peak in brain-derived neurotrophic factor in adults with Prader-Willi syndrome","volume":"11","author":"Bueno","year":"2016","journal-title":"PLoS One"},{"issue":"6","key":"key2.024011506525e+13_B31","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/S1096-6374(03)00077-7","article-title":"Peptides associated with hyperphagia in adults with Prader\u2013Willi syndrome before and during GH treatment","volume":"13","author":"H\u00f6ybye","year":"2003","journal-title":"Growth Horm IGF Res"},{"issue":"4","key":"key2.024011506525e+13_B32","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.npep.2011.06.001","article-title":"In adults with Prader\u2013Willi syndrome, elevated ghrelin levels are more consistent with hyperphagia than high PYY and GLP-1 levels","volume":"45","author":"Purtell","year":"2011","journal-title":"Neuropeptides"},{"issue":"1","key":"key2.024011506525e+13_B33","doi-asserted-by":"crossref","first-page":"E225","DOI":"10.1210\/jc.2010-1733","article-title":"The metabolic phenotype of Prader-Willi syndrome (PWS) in childhood: heightened insulin sensitivity relative to body mass index","volume":"96","author":"Haqq","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"key2.024011506525e+13_B34","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1210\/jc.2007-2138","article-title":"Hyperghrelinemia precedes obesity in Prader-Willi syndrome","volume":"93","author":"Feigerlov\u00e1","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"key2.024011506525e+13_B35","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1007\/s12020-015-0614-x","article-title":"Elevated ratio of acylated to unacylated ghrelin in children and young adults with Prader\u2013Willi syndrome","volume":"50","author":"Kuppens","year":"2015","journal-title":"Endocrine"},{"issue":"1","key":"key2.024011506525e+13_B36","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s13023-016-0440-0","article-title":"High unacylated ghrelin levels support the concept of anorexia in infants with Prader-Willi syndrome","volume":"11","author":"Beauloye","year":"2016","journal-title":"Orphanet J Rare Dis"},{"issue":"9","key":"key2.024011506525e+13_B37","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1002\/ajmg.a.37777","article-title":"Higher plasma orexin a levels in children with Prader\u2013Willi syndrome compared with healthy unrelated sibling controls","volume":"170","author":"Manzardo","year":"2016","journal-title":"Am J Med Genet A"},{"issue":"11","key":"key2.024011506525e+13_B38","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/ncpendmet0320","article-title":"Management of obesity in Prader\u2013Willi syndrome","volume":"2","author":"Butler","year":"2006","journal-title":"Nat Clin Pract Endocrinol Metab"},{"issue":"(1-2)","key":"key2.024011506525e+13_B39","first-page":"23","article-title":"Effects of metformin in children and adolescents with Prader-Willi syndrome and early-onset morbid obesity: a pilot study","volume":"27","author":"Miller","year":"2014","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"10","key":"key2.024011506525e+13_B40","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/j.1467-789X.2010.00727.x","article-title":"Expanding the definition of hypothalamic obesity","volume":"11","author":"Hochberg","year":"2010","journal-title":"Obes Rev"},{"issue":"1","key":"key2.024011506525e+13_B41","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/clpt.2013.204","article-title":"Antiobesity pharmacotherapy: new drugs and emerging targets","volume":"95","author":"Kim","year":"2014","journal-title":"Clin Pharmacol Ther"},{"issue":"10","key":"key2.024011506525e+13_B42","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1210\/jc.2011-1256","article-title":"A one-year randomized trial of lorcaserin for weight loss in obese and overweight adults: the BLOSSOM trial","volume":"96","author":"Fidler","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"key2.024011506525e+13_B43","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/apa.12898","article-title":"Growth hormone treatment of Prader\u2013Willi syndrome has long-term, positive effects on body composition","volume":"104","author":"H\u00f6ybye","year":"2015","journal-title":"Acta Paediatr"},{"issue":"6","key":"key2.024011506525e+13_B44","doi-asserted-by":"crossref","first-page":"E1072","DOI":"10.1210\/jc.2012-3888","article-title":"Growth hormone research society workshop summary: consensus guidelines for recombinant human growth hormone therapy in Prader-Willi syndrome","volume":"98","author":"Deal","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"key2.024011506525e+13_B45","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1210\/jc.2009-1389","article-title":"Long-term growth hormone therapy changes the natural history of body composition and motor function in children with Prader-Willi syndrome","volume":"95","author":"Carrel","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"key2.024011506525e+13_B46","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1002\/ajmg.a.31468","article-title":"Two years of growth hormone therapy in young children with Prader\u2013Willi syndrome: physical and neurodevelopmental benefits","volume":"143A","author":"Myers","year":"2007","journal-title":"Am J Med Genet A"},{"issue":"4","key":"key2.024011506525e+13_B47","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1530\/EJE-08-0462","article-title":"Long-acting octreotide treatment causes a sustained decrease in ghrelin concentrations but does not affect weight, behaviour and appetite in subjects with Prader\u2013Willi syndrome","volume":"159","author":"De Waele","year":"2008","journal-title":"Eur J Endocrinol"},{"issue":"8","key":"key2.024011506525e+13_B48","doi-asserted-by":"crossref","first-page":"4162","DOI":"10.1210\/jc.2004-0835","article-title":"Somatostatin infusion lowers plasma ghrelin without reducing appetite in adults with Prader-Willi syndrome","volume":"89","author":"Tan","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"key2.024011506525e+13_B49","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/s41398-019-0597-0","article-title":"Effect of topiramate on eating behaviours in Prader-Willi syndrome: TOPRADER double-blind randomised placebo-controlled study","volume":"9","author":"Consoli","year":"2019","journal-title":"Transl Psychiatry"},{"issue":"1","key":"key2.024011506525e+13_B50","doi-asserted-by":"crossref","first-page":"52","DOI":"10.6065\/apem.2020.25.1.52","article-title":"Successful rapid weight reduction and the use of liraglutide for morbid obesity in adolescent Prader-Willi syndrome","volume":"25","author":"Kim","year":"2020","journal-title":"Ann Pediatr Endocrinol Metab"},{"issue":"3","key":"key2.024011506525e+13_B51","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/ijpo.12131","article-title":"Effects of exenatide on weight and appetite in overweight adolescents and young adults with Prader-Willi syndrome","volume":"12","author":"Salehi","year":"2017","journal-title":"Pediatr Obes"},{"issue":"10","key":"key2.024011506525e+13_B52","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1507\/endocrj.EJ12-0074","article-title":"The glucagon-like peptide-1 analog liraglutide suppresses ghrelin and controls diabetes in a patient with Prader-Willi syndrome","volume":"59","author":"Senda","year":"2012","journal-title":"Endocr J"},{"issue":"4","key":"key2.024011506525e+13_B53","doi-asserted-by":"crossref","first-page":"e76","DOI":"10.2337\/dc13-2575","article-title":"Use of GLP-1 receptor agonists in Prader-Willi syndrome: report of six cases","volume":"37","author":"Fintini","year":"2014","journal-title":"Diabetes Care"},{"issue":"7","key":"key2.024011506525e+13_B54","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0011749","article-title":"Unacylated ghrelin rapidly modulates lipogenic and insulin signaling pathway gene expression in metabolically active tissues of GHSR deleted mice","volume":"5","author":"Delhanty","year":"2010","journal-title":"PLoS One"},{"issue":"1","key":"key2.024011506525e+13_B55","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0190849","article-title":"AZP-531, an unacylated ghrelin analog, improves food-related behavior in patients with Prader-Willi syndrome: a randomized placebo-controlled trial","volume":"13","author":"Allas","year":"2018","journal-title":"PLoS One"},{"issue":"(6-8)","key":"key2.024011506525e+13_B56","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1080\/09687688.2017.1388930","article-title":"The octanoylated energy regulating hormone ghrelin: an expanded view of ghrelin's biological interactions and avenues for controlling ghrelin signaling","volume":"33","author":"Cleverdon","year":"2016","journal-title":"Mol Membr Biol"},{"issue":"1","key":"key2.024011506525e+13_B57","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1042\/BST20180436","article-title":"Ghrelin octanoylation by ghrelin O-acyltransferase: unique protein biochemistry underlying metabolic signaling","volume":"47","author":"Hougland","year":"2019","journal-title":"Biochem Soc Trans"},{"issue":"3","key":"key2.024011506525e+13_B58","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s40265-021-01470-9","article-title":"Setmelanotide: first approval","volume":"81","author":"Markham","year":"2021","journal-title":"Drugs"},{"issue":"10","key":"key2.024011506525e+13_B59","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/s41574-022-00716-0","article-title":"The promise of new anti-obesity therapies arising from knowledge of genetic obesity traits","volume":"18","author":"Hinney","year":"2022","journal-title":"Nat Rev Endocrinol"},{"issue":"11","key":"key2.024011506525e+13_B60","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1111\/dom.14133","article-title":"Effect of setmelanotide, a melanocortin-4 receptor agonist, on obesity in Bardet-Biedl syndrome","volume":"22","author":"Haws","year":"2020","journal-title":"Diabetes Obes Metab"},{"key":"key2.024011506525e+13_B61","doi-asserted-by":"crossref","first-page":"100780","DOI":"10.1016\/j.conctc.2021.100780","article-title":"The efficacy and safety of setmelanotide in individuals with Bardet-Biedl syndrome or Alstr\u00f6m syndrome: phase 3 trial design","volume":"22","author":"Haws","year":"2021","journal-title":"Contemp Clin Trials Commun"},{"issue":"9","key":"key2.024011506525e+13_B62","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0221615","article-title":"A randomized pilot efficacy and safety trial of diazoxide choline controlled-release in patients with Prader-Willi syndrome","volume":"14","author":"Kimonis","year":"2019","journal-title":"PLoS One"},{"key":"key2.024011506525e+13_B63","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/7854_2017_28","article-title":"Oxytocin and Prader-Willi syndrome","volume":"35","author":"Kabasakalian","year":"2018","journal-title":"Curr Top Behav Neurosci"},{"issue":"12","key":"key2.024011506525e+13_B64","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.98333","article-title":"Intranasal carbetocin reduces hyperphagia in individuals with Prader-Willi syndrome","volume":"3","author":"Dykens","year":"2018","journal-title":"JCI Insight"},{"issue":"12","key":"key2.024011506525e+13_B65","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1111\/dom.13021","article-title":"Effects of MetAP2 inhibition on hyperphagia and body weight in Prader\u2013Willi syndrome: a randomized, double-blind, placebo-controlled trial","volume":"19","author":"McCandless","year":"2017","journal-title":"Diabetes Obes Metab"},{"issue":"2","key":"key2.024011506525e+13_B66","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1124\/jpet.117.246272","article-title":"Preclinical efficacy and safety of the novel antidiabetic, antiobesity MetAP2 inhibitor ZGN-1061","volume":"365","author":"Burkey","year":"2018","journal-title":"J Pharmacol Exp Ther"}],"container-title":["The Ewha Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.e-emj.org\/download\/download_pdf?doi=10.12771\/emj.2023.e33","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.e-emj.org\/download\/download_pdf?doi=10.12771\/emj.2023.e33","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T02:08:03Z","timestamp":1741226883000},"score":1,"resource":{"primary":{"URL":"https:\/\/e-emj.org\/journal\/view.php?doi=10.12771\/emj.2023.e33"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,31]]},"references-count":66,"journal-issue":{"issue":"s1","published-online":{"date-parts":[[2023,12,31]]}},"alternative-id":["10.12771\/emj.2023.e33"],"URL":"https:\/\/doi.org\/10.12771\/emj.2023.e33","relation":{},"ISSN":["2234-2591"],"issn-type":[{"value":"2234-2591","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,31]]},"assertion":[{"value":"2023-11-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-12-18","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e33"}}